Simply Wall St.
Does Medline’s Muted 2025 Share Price Mask a More Attractive Valuation Story?
📉
AI Sentiment
Negative
3/10
- Home
- MDLN
MDLN
Medline Inc. Class A Common Stock
as of 12-23-2025 3:45pm EST
$43.86
+$1.67
+3.97%
| Founded: | 1966 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 54.8B | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 29.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.07 | EPS Growth: | 441.66 |
| 52 Week Low/High: | $34.89 - $43.90 | Next Earning Date: | 01-01-0001 |
| Revenue: | $27,429,000,000 | Revenue Growth: | 18.07% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Medline Inc. Class A Common Stock (MDLN)
Mozart Aggregator II LP
Sell
10% Owner
MDLN Dec 18, 2025
Avg Cost/Share
$28.37
Shares
13,462,600
Total Value
$381,911,075.58
Owned After
143,187,216
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Mozart Aggregator II LP | MDLN | 10% Owner | Dec 18, 2025 | Sell | $28.37 | 13,462,600 | $381,911,075.58 | 143,187,216 |
Latest Medline Inc. Class A Common Stock News
MDLN Breaking Stock News: Dive into MDLN Ticker-Specific Updates for Smart Investing
Insider Monkey
“I Was Very Impressed” by Medline (MDLN)’s IPO, Says Jim Cramer
📊
AI Sentiment
Positive
7/10
Insider Monkey
Jim Cramer Says Medline IPO “Went so Well” That it Looks “A Little Too Expensive”
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
IPO Stocks Can Be Lucrative: Here's How To Buy Them
➖
AI Sentiment
Neutral
5/10
Barrons.com
These Stocks Moved the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
📈
AI Sentiment
Highly Positive
8/10
Compare MDLN vs Leading Stocks
See how MDLN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDLN Medline Inc. Class A Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.